Evidence map›Paper›PMID 27054571›Full record

Trial reportPloS one2016

Association of Common Polymorphisms in the Nicotinic Acetylcholine Receptor Alpha4 Subunit Gene with an Electrophysiological Endophenotype in a Large Population-Based Sample.

A Mobascher, A Diaz-Lacava, M Wagner, J Gallinat, T F Wienker, D Drichel, T Becker, M Steffens, N Dahmen, G Gründer and 8 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Nicotinic α4β2 Cholinergic Receptor Influences on Dorsolateral Prefrontal Cortical Neuronal Firing during a Working Memory Task.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 1 country.

A MobascherDepartment of Psychiatry, Mainz University Hospital, Mainz, Germany.
A Diaz-LacavaCologne Center for Genomics, University of Cologne, Cologne, Germany.
M WagnerDepartment of Psychiatry, Bonn University Hospital, Bonn, Germany.
J GallinatDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany.
T F WienkerMax-Planck Institute for Molecular Genetics, Berlin, Germany.
D DrichelUniversity of Greifswald, Greifswald, Germany.
T BeckerUniversity of Greifswald, Greifswald, Germany.
M SteffensResearch Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
N DahmenDepartment of Psychiatry, Mainz University Hospital, Mainz, Germany.
G GründerDepartment of Psychiatry, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, University Hospital, Aachen, Germany.
N ThüraufDepartment of Psychiatry, Friedrich-Alexander University, University Hospital, Erlangen- Nürnberg, Erlangen, Germany.
F KieferDepartment of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany.
J KornhuberDepartment of Psychiatry, Friedrich-Alexander University, University Hospital, Erlangen- Nürnberg, Erlangen, Germany.
M R ToliatCologne Center for Genomics, University of Cologne, Cologne, Germany.
H ThieleCologne Center for Genomics, University of Cologne, Cologne, Germany.
P NürnbergCologne Center for Genomics, University of Cologne, Cologne, Germany.
O SteinleinDepartment of Human Genetics, Ludwig-Maximilians University, Munich, Germany.
G WintererExperimental and Clinical Research Center (ECRC), Charité - University Medicine, Berlin, Germany.
University of Cologne · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEJohannes Gutenberg University Mainz · DEUniversität Greifswald · DECentral Institute of Mental Health · DECharité - Universitätsmedizin Berlin · DEFederal Institute for Drugs and Medical Devices · DELudwig-Maximilians-Universität München · DEMax Planck Institute for Molecular Genetics · DERWTH Aachen University · DEUniversity Hospital Bonn · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Variation in genes coding for nicotinic acetylcholine receptor (nAChR) subunits affect cognitive processes and may contribute to the genetic architecture of neuropsychiatric disorders. Single nucleotide polymorphisms (SNPs) in the CHRNA4 gene that codes for the alpha4 subunit of alpha4/beta2-containing receptors have previously been implicated in aspects of (mostly visual) attention and smoking-related behavioral measures. Here we investigated the effects of six synonymous but functional CHRNA4 exon 5 SNPs on the N100 event-related potential (ERP), an electrophysiological endophenotype elicited by a standard auditory oddball. A total of N = 1,705 subjects randomly selected from the general population were studied with electroencephalography (EEG) as part of the German Multicenter Study on nicotine addiction. Two of the six variants, rs1044396 and neighboring rs1044397, were significantly associated with N100 amplitude. This effect was pronounced in females where we also observed an effect on reaction time. Sequencing of the complete exon 5 region in the population sample excluded the existence of additional/functional variants that may be responsible for the observed effects. This is the first large-scale population-based study investigation the effects of CHRNA4 SNPs on brain activity measures related to stimulus processing and attention. Our results provide further evidence that common synonymous CHRNA4 exon 5 SNPs affect cognitive processes and suggest that they also play a role in the auditory system. As N100 amplitude reduction is considered a schizophrenia-related endophenotype the SNPs studied here may also be associated with schizophrenia outcome measures.

Indexed as

AdultElectrophysiological PhenomenaEndophenotypesFemaleGermanyHumansMaleNeuroimagingPolymorphism, Single NucleotideReceptors, NicotinicSmokingTobacco Use DisorderReceptors, Nicotinic

Identifiers

PMID27054571
PMCPMC4824511
OpenAlexW2320156930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.